Optimal Production of 3D Neuronal Lineage Population by Morphological Classification.

Area of Science:

• Neuroscience
• Stem Cell Biology
• Toxicology

Background:

• Rising neurodegenerative diseases and toxic exposures necessitate advanced human neuronal models.
• Human pluripotent stem cell (hPSC)-derived 3D models offer superior physiological mimicry and enable personalized medicine.
• Current models face variable differentiation efficiency, requiring standardized protocols.

Purpose of the Study:

• To optimize the generation of human pluripotent stem cell (hPSC)-derived neuronal organoids.
• To establish criteria for selecting efficient neuronal differentiation models.
• To validate the utility of optimized organoids for drug toxicity testing.

Main Methods:

• Morphological analysis of hPSC-derived embryonic bodies (EBs) in concave microwells during early neuronal differentiation.
• Establishment of criteria for high differentiation efficiency across diverse cell lines.
• Generation of neuronal organoids using microfluidic chips and assessment of drug toxicity sensitivity.

Main Results:

• Embryonic bodies (EBs) formed in 500 µm concave microwells showed peak neuronal differentiation efficiency.
• Cavity-like EBs proved more effective for neuronal differentiation and maturation than cystic-like structures.
• An optimized protocol for neuronal lineage differentiation was developed and validated for drug toxicity testing.

Conclusions:

• Morphological classification of EBs identified optimal structures for neuronal differentiation.
• A standardized method for generating neuronal organoids was established, applicable to various cell lines.
• The optimized method facilitates patient-specific treatments and enhances drug toxicity evaluations.